NanoEntek, Inc. (KOSDAQ:039860)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,830.00
-210.00 (-2.98%)
At close: Feb 27, 2026
87.64%
Market Cap 260.18B
Revenue (ttm) 34.74B
Net Income (ttm) 2.68B
Shares Out 38.09M
EPS (ttm) 81.48
PE Ratio 83.83
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,606,298
Average Volume 2,419,206
Open 7,300.00
Previous Close 7,040.00
Day's Range 6,680.00 - 7,420.00
52-Week Range 2,950.00 - 9,390.00
Beta 0.45
RSI 65.41
Earnings Date Mar 17, 2026

About NanoEntek

NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a residual white blood cell counters; ADAMII/fluorescence stem cell counter; fluorescence cell counters and cell analyzers; brightfield cell counters; somatic... [Read more]

Industry Laboratory Analytical Instruments
Founded 1987
Employees 97
Stock Exchange KOSDAQ
Ticker Symbol 039860
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.